Syntrix Biosystems Sues Illumina for IP Infringement, Breach of Contract
November 30, 2010
Syntrix Biosystems Sues Illumina for IP Infringement, Breach of Contract
In the suit, Syntrix alleges that Illumina has based its array products on technology developed originally by Syntrix and provided confidentially to Illumina a decade ago while the two firms were discussing a possible business relationship.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Jury Trial Commences in Suit That Alleges Illumina's Array Products Violate Syntrix's IP
March 5, 2013 / BioArray News - People in the News: Matt Posard
April 2, 2013 / BioArray News - Jury Orders Illumina to Pay $96M for Infringing Syntrix's Array IP
March 19, 2013 / BioArray News - Court Orders Illumina to Pay Syntrix $96M for Patent Infringement
March 15, 2013 / GenomeWeb Daily News - Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News